|
시장보고서
상품코드
2065254
협측 약물전달 시스템 시장 규모, 점유율, 성장 분석 : 제형별, 약제 종류별, 용도별, 방출 유형별, 최종사용자별, 유통 채널별, 지역별 - 업계 예측(2026-2033년)Buccal Drug Delivery Systems Market Size, Share, and Growth Analysis, By Dosage Form, By Drug Type, By Application, By Release Type, By End User, By Distribution Channel, By Region - Industry Forecast 2026-2033 |
||||||
세계의 협측 약물전달 시스템 시장 규모는 2024년에 56억 달러로 평가되었으며, 2025년 60억 5,000만 달러에서 2033년까지 112억 9,000만 달러로 확대되어 예측 기간(2026-2033년) 동안 CAGR 8.1%로 성장할 것으로 전망됩니다.
전 세계 협측 약물전달 시스템 시장은 인구 동향의 변화와 만성 질환 유병률 증가에 힘입어 눈부신 성장을 이루고 있습니다. 이러한 요인들은 비침습적이고 환자에게 부담이 적은 투여 방식에 대한 수요를 촉진하고 있습니다. 이 혁신적인 분야는 기존의 정제에서 박막, 점막 부착형 패치, 나노입자 강화 매트릭스 등 첨단 제형으로 진화하여, 첫 통과 대사를 회피하면서도 약물의 흡수를 최적화하고 있습니다. 점막 부착성 고분자 및 투과 촉진제 분야의 최근 발전은 약물의 체류 시간과 구강 점막을 통한 투과성을 높임으로써 시장 확대를 더욱 가속화하고 있습니다. 그 결과, 각 기업은 환자 중심의 제제에 대한 규제상의 우대 조치와 임상시험의 증가에 힘입어, 펜타닐 구강 점막 정제나 실험 단계에 있는 인슐린 패치 등의 제품 개발을 위해 구강 점막 투여 플랫폼에 적극적으로 투자하고 있으며, 전 세계적으로 라이선싱 및 제조 분야에서 광범위한 기회를 창출하고 있습니다.
전 세계 협측 약물전달 시스템 시장의 성장요인
전 세계 협측 약물전달 시스템 시장은 비침습적 투여가 주는 이점으로 인해 성장하고 있습니다. 이 투여법은 환자의 치료 순응도를 높이고, 주사나 복잡한 경구 투여법을 대체할 수 있는 바람직한 대안을 제공합니다. 이 방법을 사용하면 점막을 통해 직접 흡수될 수 있어 전신성 부작용을 줄이고, 위장 내 분해를 방지하며, 민감한 화합물에 대한 치료 효과의 일관성을 높일 수 있습니다. 간소화된 자가 투여 과정과 환자의 편의성 향상은 만성 질환 관리를 담당하는 임상의와 간병인들의 수용을 더욱 촉진하고 있습니다. 그 결과, 보다 광범위한 도입이 촉진되고, 다양한 의료 환경에서의 수요가 증가함에 따라 시장 전체의 확대에 큰 영향을 미치고 있습니다.
세계 협측 약물전달 시스템 시장의 제약요인
전 세계 협측 약물전달 시스템 시장은 주로 이러한 제품과 관련된 복잡한 승인 절차로 인해 큰 어려움에 직면해 있습니다. 엄격한 규제 요건으로 인해 개발자는 점막의 안전성 및 국소 자극에 관한 구체적인 데이터를 제출해야 하므로, 개발 기간이 길어질 수밖에 없습니다. 이는 특히 지역마다 기준이 다르거나 특정 구강 점막 제제에 관한 확립된 선례가 없는 경우, 후원사에게 불확실성을 초래합니다. 그 결과, 복잡한 규제 환경이 개발 위험을 높임으로써 중소기업의 혁신적인 구강 점막용 후보 약물 개발에 대한 의욕을 저해할 가능성이 있습니다. 이러한 상황은 결국 상용화 노력을 저해하게 되며, 과학적 타당성과 잠재적인 임상적 이점이 있음에도 불구하고 시장에서 신제품의 공급을 제한하게 될 것입니다.
세계 협측 약물전달 시스템 시장의 동향
전 세계 협측 약물전달 시스템 시장에서는 환자 중심의 제형 혁신을 향한 뚜렷한 추세가 나타나고 있습니다. 각 제약사는 맛 가림 및 투여 일정 간소화와 같은 첨단 기술을 통해 환자의 편의성과 복약 순응도를 높이는 제제를 점점 더 우선시하고 있습니다. 이러한 변화는 점막 부착성 부형제의 개선과 눈에 띄지 않는 투여 형태의 보급에 힘입어, 소아 및 고령층에서의 채택률 향상에 기여하고 있습니다. 또한, 관능 평가 및 인체공학 전문가들과의 협력을 통해 패키지를 설계함으로써, 이러한 시스템의 실제 효능이 향상되고 있습니다. 이러한 환자 요구에 집중함으로써 제품의 차별화와 개선을 지속적으로 촉진하고 있으며, 뺨 점막 투여 시스템을 치료 투여에 있어 보다 현실적인 대안으로 자리매김하고 있습니다.
자주 묻는 질문
목차
소개
조사 방법
주요 요약
시장 역학과 전망
주요 시장 인사이트
세계의 협측 약물전달 시스템 시장 규모 : 제형별
세계의 협측 약물전달 시스템 시장 규모 : 약물 유형별
세계의 협측 약물전달 시스템 시장 규모 : 용도별
세계의 협측 약물전달 시스템 시장 규모 : 방출 유형별
세계의 협측 약물전달 시스템 시장 규모 : 최종사용자별
세계의 협측 약물전달 시스템 시장 규모 : 유통 채널별
세계의 협측 약물전달 시스템 시장 규모 : 지역별
경쟁 정보
주요 기업 개요
결론과 제안
KSM 26.06.25Global Buccal Drug Delivery Systems Market size was valued at USD 5.60 Billion in 2024 and is poised to grow from USD 6.05 Billion in 2025 to USD 11.29 Billion by 2033, growing at a CAGR of 8.1% during the forecast period (2026-2033).
The global buccal drug delivery systems market is witnessing significant growth driven by a demographic shift and an increasing prevalence of chronic diseases, which stimulate demand for non-invasive, patient-friendly administration methods. This innovative landscape has evolved from traditional tablets to advanced formats like thin films, mucoadhesive patches, and nanoparticle-enhanced matrices, optimizing drug absorption while circumventing first-pass metabolism. Recent advancements in mucoadhesive polymers and permeation enhancers have further catalyzed market expansion by enhancing drug residence time and permeability through the buccal mucosa. As a result, companies are actively investing in buccal platforms to develop products such as fentanyl buccal tablets and experimental insulin patches, supported by regulatory incentives for patient-focused formulations and increased clinical trials, creating extensive opportunities in licensing and manufacturing globally.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Buccal Drug Delivery Systems market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Buccal Drug Delivery Systems Market Segments Analysis
Global buccal drug delivery systems market is segmented by dosage form, drug type, application, release type, end user, distribution channel and region. Based on dosage form, the market is segmented into buccal tablets, buccal films, buccal patches, buccal sprays, buccal gels and others. Based on drug type, the market is segmented into analgesics, hormones, cardiovascular drugs, CNS drugs, smoking cessation drugs and others. Based on application, the market is segmented into pain management, hormone replacement therapy, cardiovascular disorders, neurological disorders, smoking cessation and others. Based on release type, the market is segmented into Immediate release and controlled release. Based on end user, the market is segmented into hospitals, clinics and homecare settings. Based on distribution channel, the market is segmented into hospital pharmacies, retail pharmacies and online pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Buccal Drug Delivery Systems Market
The Global Buccal Drug Delivery Systems market is experiencing growth due to the advantages of noninvasive administration that enhance patient compliance, offering a preferable alternative to injections and intricate oral regimens. This method allows for direct mucosal absorption, which can mitigate systemic side effects, prevent gastrointestinal degradation, and provide improved therapeutic consistency for sensitive compounds. The simplified self-administration process and increased comfort perceived by patients further encourage acceptance among clinicians and caregivers involved in chronic disease management. Consequently, this supports broader implementation and drives demand across various healthcare environments, ensuring a significant impact on overall market expansion.
Restraints in the Global Buccal Drug Delivery Systems Market
The Global Buccal Drug Delivery Systems market faces significant challenges primarily due to the convoluted approval processes associated with these products. Stringent regulatory requirements necessitate extensive development timelines, as developers must provide specific data on mucosal safety and local irritation. This creates uncertainty for sponsors, particularly when dealing with varying standards across different regions and the lack of established precedents for certain buccal formulations. Consequently, the intricate regulatory landscape heightens development risks and may deter smaller companies from pursuing innovative buccal candidates. This situation ultimately hampers commercialization efforts, restricting the availability of new products in the market despite their scientific viability and potential clinical benefits.
Market Trends of the Global Buccal Drug Delivery Systems Market
The Global Buccal Drug Delivery Systems market is witnessing a significant trend towards patient-centric formulation innovation. Companies are increasingly prioritizing formulations that enhance patient comfort and adherence through advanced techniques such as taste-masking and simplified dosing regimens. This shift is contributing to higher adoption rates among pediatric and geriatric populations, driven by improvements in mucoadhesive excipients and discreet delivery formats. Moreover, sensory profiling and collaborative packaging design with human factors experts are enhancing the real-world effectiveness of these systems. This focus on patient needs is fostering iterative product differentiation and refinement, positioning buccal delivery systems as a more viable option in therapeutic administration.
Table of Contents
Introduction
- Objectives of the Study
- Market Definition & Scope
Research Methodology
- Research Process
- Secondary & Primary Data Methods
- Market Size Estimation Methods
Executive Summary
- Global Market Outlook
- Key Market Highlights
- Segmental Overview
- Competition Overview
Market Dynamics & Outlook
- Macro-Economic Indicators
- Drivers & Opportunities
- Restraints & Challenges
- Supply Side Trends
- Demand Side Trends
- Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Key Market Insights
- Key Success Factors
- Market Impacting Factors
- Top Investment Pockets
- Ecosystem Mapping
- Market Attractiveness Index 2025
- PESTEL Analysis
- Regulatory Landscape
- Value Chain Analysis
- Case Studies
- Technology Assessment
- Customer & Buying Criteria Analysis
- Pipeline Analysis
- Disease Epidemiology
Global Buccal Drug Delivery Systems Market Size by Dosage Form & CAGR (2026-2033)
- Market Overview
- Buccal Tablets
- Buccal Films
- Buccal Patches
- Buccal Sprays
- Buccal Gels
- Others
Global Buccal Drug Delivery Systems Market Size by Drug Type & CAGR (2026-2033)
- Market Overview
- Analgesics
- Hormones
- Cardiovascular Drugs
- CNS Drugs
- Smoking Cessation Drugs
- Others
Global Buccal Drug Delivery Systems Market Size by Application & CAGR (2026-2033)
- Market Overview
- Pain Management
- Hormone Replacement Therapy
- Cardiovascular Disorders
- Neurological Disorders
- Smoking Cessation
- Others
Global Buccal Drug Delivery Systems Market Size by Release Type & CAGR (2026-2033)
- Market Overview
- Immediate Release
- Controlled Release
Global Buccal Drug Delivery Systems Market Size by End User & CAGR (2026-2033)
- Market Overview
- Hospitals
- Clinics
- Homecare Settings
Global Buccal Drug Delivery Systems Market Size by Distribution Channel & CAGR (2026-2033)
- Market Overview
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Buccal Drug Delivery Systems Market Size & CAGR (2026-2033)
- North America (Dosage Form, Drug Type, Application, Release Type, End User, Distribution Channel)
- US
- Canada
- Europe (Dosage Form, Drug Type, Application, Release Type, End User, Distribution Channel)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Dosage Form, Drug Type, Application, Release Type, End User, Distribution Channel)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Dosage Form, Drug Type, Application, Release Type, End User, Distribution Channel)
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa (Dosage Form, Drug Type, Application, Release Type, End User, Distribution Channel)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2025
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2025
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)
Key Company Profiles
- Viatris
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Aquestive Therapeutics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- IntelGenx Technologies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cure Pharmaceutical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- AdhexPharma
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Tapemark
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- ARx LLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Kindeva Drug Delivery
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- LTS Lohmann Therapie-Systeme
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- ZIM Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Aphios Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- NemuBio
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Aveva Drug Delivery Systems
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- MedRx Co.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Ensysce Biosciences
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Collegium Pharmaceutical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Aquestive Therapeutics Technologies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- BioXcel Therapeutics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Aquestive Therapeutics Manufacturing
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cipla
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
